$0.6200
Last update: Dec 31, 7:00 PM
Comments
Loading...
Ampio Pharmaceuticals (OTC:AMPE) Stock, Earnings Estimates, EPS, And Revenue
Ampio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS
$-2.480
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Ampio Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Ampio Pharmaceuticals (AMPE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2022 | 2022-11-14 | $-10.00 | $-6.00 | -66.7 % |
| Jun 2022 | 2022-08-09 | $-6.00 | $-6.00 | 0.00 % |
| Mar 2022 | 2022-05-16 | $-9.00 | $-6.00 | -50.0 % |
| Dec 2021 | 2022-03-29 | $-12.00 | $-6.00 | -100.0 % |
Ampio Pharmaceuticals (AMPE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Ampio Pharmaceuticals (OTCEM:AMPE) reporting earnings?
Ampio Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 27, 2024 for Q4.
What were the latest earnings per share (EPS) for Ampio Pharmaceuticals (OTCEM:AMPE)?
Ampio Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 27, 2024 for Q4 and the Actual EPS was $-2.48, which missed the estimate of $0.00.
What were Ampio Pharmaceuticals’s (OTCEM:AMPE) revenues?
Ampio Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 27, 2024 for Q4 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.